Hypervascular pancreatic “lesions”: a pattern-based approach to differentiation
- 921 Downloads
Hypervascular pancreatic lesions/masses can arise due to a variety of causes, both benign and malignant, leading to a wide differential diagnosis. Accurate differentiation of these lesions into appropriate diagnoses can be challenging; however, this is important for directing clinical management. This manuscript provides a multimodality imaging review of hypervascular pancreatic lesion, with emphasis on an imaging-based algorithmic approach for differentiation of these lesions, which may serve as a decision support tool when encountering these uncommon lesions. Additionally, we stratify these lesions into three categories based on malignant potential, to help guide clinical management.
KeywordsPancreas Hypervascular masses Decision support Neuroendocrine tumor Pancreatic neoplasm
Compliance with ethical standards
No funding was received for this study.
Conflict of interest
All authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
Statement of informed consent was not applicable since the manuscript does not contain any patient data.
- 14.Coquia SF, Kawamoto S, Zaheer A, et al. (2014) Intrapancreatic accessory spleen: possibilities of computed tomography in differentiation from nonfunctioning pancreatic neuroendocrine tumor. J Comput Assist Tomogr 38(6):874–878. doi: 10.1097/rct.0000000000000127 CrossRefPubMedPubMedCentralGoogle Scholar
- 31.Nihei K, Sakamoto K, Suzuki S, Mishina T, Otaki M (2016) A case of pancreatic metastasis of renal cell carcinoma. Gan Kagaku Ryoho Cancer Chemother 43(12):2274–2276Google Scholar
- 38.Cho JH, Ryu JK, Song SY, et al. (2016) Prognostic validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging classifications for pancreatic neuroendocrine tumors: a retrospective nationwide multicenter study in South Korea. Pancreas 45(7):941–946. doi: 10.1097/mpa.0000000000000586 CrossRefPubMedGoogle Scholar
- 45.Mojtahedi A, Thamake S, Tworowska I, Ranganathan D, Delpassand ES (2014) The value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature. Am J Nucl Med Mol Imaging 4(5):426–434PubMedPubMedCentralGoogle Scholar